Pathway to artificial pancreas systems revisited: moving downstream

Area of Science:

• Biomedical Engineering
• Endocrinology
• Diabetes Technology

Background:

• Artificial pancreas (AP) systems aim to replicate natural islet function lost in diabetes.
• Significant advancements have been made in AP system development and automation of insulin delivery.
• Previous roadmaps guided AP research, but current progress necessitates an update.

Purpose of the Study:

• To review the current state of artificial pancreas systems.
• To assess the feasibility and safety of AP systems in clinical and real-world settings.
• To discuss the future challenges and requirements for widespread AP adoption and integration into diabetes care.

Main Methods:

• Review of clinical research and real-world data on AP system performance.
• Analysis of the iterative roadmap for AP system development.
• Evaluation of factors influencing clinical and patient adoption of AP technology.

Main Results:

• AP systems have demonstrated safety and feasibility in both clinical research and outpatient settings.
• Technical feasibility of AP systems is established.
• Widespread adoption by clinicians and patients is not yet certain.

Conclusions:

• Artificial pancreas systems are technically ready for broader application.
• Successful integration into the healthcare system and improved patient outcomes are critical for AP success.
• Future efforts must focus on adoption strategies and healthcare system integration to realize the full potential of AP technology.